---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-069099"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:54:04.684021+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# TELA Bio appoints Jeffrey Blizard to Board; stockholders re-elect directors

## Summary
- Jeffrey Blizard, Global Head of Surgical Sales at Abiomed (J&J MedTech), appointed to Board as Class III director, term to 2025 annual meeting.
- Initial equity grant: option for 9,300 shares vesting monthly over 36 months and RSU for 6,375 shares vesting in three annual installments.
- Annual retainer: $45,000 for Board service plus $5,000 for Nominating Committee.
- Stockholders elected Kurt Azarbarzin (17,037,112 for) and Antony Koblish (18,742,180 for) as Class II directors; KPMG ratified as auditor for FY2024.

## SEC filing metadata
- accession: 0001104659-24-069099
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465924069099/0001104659-24-069099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465924069099/tm2416416d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-069099
- JSON: https://secwatch.observer/filing/0001104659-24-069099.json
- Plain text: https://secwatch.observer/filing/0001104659-24-069099.txt

## Key facts
- Executive change
  Jeffrey Blizard was appointed as member of the Board of Directors at TELA Bio, Inc..
  - Action: appointed
  - Role: member of the Board of Directors
  source text: On June 4, 2024, TELA Bio, Inc. (the “ Company ”) appointed Jeffrey Blizard as a member of the Company’s Board of Directors (the “ Board ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1561921/000110465924069099/0001104659-24-069099-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.